BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ziaee M, Ebrahimzadeh A, Azarkar Z, Namaei MH, Saburi A, Fereidouni M, Bijari B, Karamian M, Sharifzadeh G. Seroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran. Hepat Mon 2016;16:e36452. [PMID: 27822260 DOI: 10.5812/hepatmon.36452] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Pouri AA, Ghojazadeh M, Shirmohammadi M, Eftekhar-Sadat AT, Somi MH. Seroepidemiology and Risk Factors of Hepatitis B Virus Infection: A Population-Based Azar Cohort Study. Iran J Public Health 2020;49:2152-60. [PMID: 33708736 DOI: 10.18502/ijph.v49i11.4733] [Reference Citation Analysis]
2 Osmani F, Azarkar G. Fitting logistic regression models to assess vitamin D deficiency with clinical parameters in chronic hepatitis B patients. Infect Dis Model 2021;6:612-7. [PMID: 33898881 DOI: 10.1016/j.idm.2021.03.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Safari H, Anani Sarab G, Fereidouni M, Ziaee M, Mahavar N, Naghizadeh MS, Taene A, Mahdavi R, Naseri M. The CCR5-∆32 Mutation: Impact on Disease Outcome in Individuals with Hepatitis B Infection in the Southern Khorasan Population (East of Iran). Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.55014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
4 Naghizadeh MS, Naseri M, Fereyduni M, Ziaee M, Tane A, Safari H, Mahavar N, Mahdavi R, Anani Sarab G; Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran, Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran, Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran, 3Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran, Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran, Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran, Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran, 4Department of Immunology, Birjand University of Medical Sciences, Birjand, Iran, Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran. Single Nucleotide Polymorphism of the Interferon-γ Gene (IFN-γ +874 T/A) and the Prognosis of Hepatitis B Infection. JoMMID 2018;6:43-7. [DOI: 10.29252/jommid.6.2.3.43] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Mahavar N, Fereidouni M, Ziaee M. Seroprevalence of Hepatitis A Virus among Healthy Individuals in Birjand, Eastern Region of Iran. Hepat Mon 2018;18. [DOI: 10.5812/hepatmon.68168] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Noreen A, Alam N, Syed Z, Aftab A, Shamim F, Najeebullah S, Khan D, Kakar SJ, Ahmed T, Adnan F. Prevalence and assessment of the associated risk factors of hepatitis B and C infections in the low socioeconomic communities. Future Virology. [DOI: 10.2217/fvl-2021-0060] [Reference Citation Analysis]
7 Javanmard D, Alavian SM, Abedi F, Namaei MH, Asghari A, Ziaee M. High Prevalence of Hepatitis B Virus Infection in the Village of Esfandiar in South Khorasan Province, Iran. Hepat Mon 2018;18. [DOI: 10.5812/hepatmon.65473] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Ziaee M, Hajihosseini M. Hepatitis Awareness Bus: A Model for Finding Unknown Hepatitis B and C Infections. Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.11719] [Reference Citation Analysis]
9 Van Remoortel H, Borra V, De Buck E, Compernolle V, Vandekerckhove P. Is an endoscopic examination associated with transfusion-transmissible infections? A systematic review and meta-analysis. Transfusion 2018;58:507-19. [PMID: 29194668 DOI: 10.1111/trf.14416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
10 Mahavar N, Naseri M, Anani Sarab G, Fereidouni M, Ziaee M, safari H, Naghizadeh MS, Tane A, Mahdavi R. IL-10 -1082 A/G (rs1800896) Polymorphism is Effective in Clearing Hepatitis B Virus Infection. Jundishapur J Microbiol 2021;14. [DOI: 10.5812/jjm.93003] [Reference Citation Analysis]
11 Hajarizadeh B, Mesgarpour B, Nasiri MJ, Alavian SM, Merat S, Poustchi H, Malekzadeh R, Sedaghat A, Haghdoost AA. Estimating the Prevalence of Hepatitis B Virus Infection and Exposure Among General Population in Iran. Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.11715] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
12 Kluger N, Fraslin JJ. [Cutaneous lesions secondary to hijama (wet cupping)]. Ann Dermatol Venereol 2018;145:62-4. [PMID: 29037426 DOI: 10.1016/j.annder.2017.08.007] [Reference Citation Analysis]
13 Namakin K, Zardast M, Naficy H, Javadinia SA. A Seroepidemiologic Study of Hepatitis A in Seven to Eighteen-Year-Old School Children in Birjand: New Concerns and Opportunities. Hepat Mon 2018;18. [DOI: 10.5812/hepatmon.65966] [Reference Citation Analysis]
14 Joukar F, Mansour-ghanaei F, Naghipour MR, Hassanipour S. Knowledge, Distribution and Risk Factors of Hepatitis B and C Infection in High-risk Groups in Guilan Province, Iran. Hepat Mon 2018;18. [DOI: 10.5812/hepatmon.65870] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
15 Mousawee SMR, Moossavi M, Bahrami A, Rasekh H, Naghizadeh MS, Abd H, Fereidouni M. The Prevalence of Hepatitis B, Hepatitis C and Human Immunodeficiency Viral Infections Among a Large Population of Afghans. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.101012] [Reference Citation Analysis]
16 Mansour-Ghanaei F, Joukar F, Naghipour M, Hassanipour S, Yeganeh S, Sepehrimanesh M, Fathalipour M. Epidemiologic profile of viral hepatitis B and C in North of Iran: results from PERSIAN Guilan Cohort Study (PGCS). BMC Res Notes 2021;14:59. [PMID: 33568187 DOI: 10.1186/s13104-021-05474-2] [Reference Citation Analysis]
17 Hariri S, Davari S, Malekzadeh Z, Mohammadi Z, Masoudi S, Gandomkar A, Amini-Kafiabad S, Maghsoudloo M, Merat S, Poustchi H, Malekzadeh F. Prevalence of Hepatitis B and C Infections and Associated Risk Factors in Pars Cohort Study, Southern Iran. Middle East J Dig Dis 2021;13:95-102. [PMID: 34712446 DOI: 10.34172/mejdd.2021.211] [Reference Citation Analysis]
18 Azarkar G, Doosti Z, Osmani F, Ziaee M. Analysis Of Risk Factors For Nonalcoholic Fatty-Liver Disease In Hepatitis B Virus Infection: A Case-Control Study. Hepat Med 2019;11:153-8. [PMID: 31749640 DOI: 10.2147/HMER.S211106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
19 Rostam-Abadi Y, Rafiemanesh H, Gholami J, Shadloo B, Amin-Esmaeili M, Rahimi-Movaghar A. Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis. Harm Reduct J 2020;17:81. [PMID: 33087141 DOI: 10.1186/s12954-020-00424-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]